Por: ABC7 Health December 01, 2022
treatment, according to new Phase 3 trial results, but the findings raise some safety concerns because of its association with certain serious adverse events.Lecanemab has become one of the first experimental dementia drugs to appear to slow the progression of cognitive decline.The long-awaited trial data, published Tuesday in the New England Journal of Medicine, comes about two months after drugmakers Biogen and Eisai announced that lecanemab... + full article
Forbes USA Business December 09, 2022
an elderly woman exercising to combat Alzheimer's disease in a care center for elderly, Galicia, ... [+] 27th November 2007. (Photo by Xurxo Lobato/Cover/Getty Images)Cover/Getty Images What should people living with dementia and their families take away from the the... + más
Reimagining Alzheimer’s (Part 4): Cautious Optimism For A New Alzheimer’s Disease Treatment | Forbes
5 things to know about the new Alzheimer’s drug — including why it may be risky for people who take blood thinners | MarketWatch
Forbes USA Tech December 05, 2022
A recent paper published in Nature reveals a new mechanism by which the genetic risk factor APOE4 ... [+] may cause Alzheimer's symptoms.American Society of Human Genetics, Allen School of Health Sciences This article is the sixth installment in my series on Alzheimer’s... + más
A Promising Trial Targets a Genetic Risk for Alzheimer’s | The New York Times
Chris Hemsworth discovers he may be at risk for Alzheimer’s disease in new series, ‘Limitless’ | ABC News
Forbes USA Business December 03, 2022
Regularly reported drug trials tell us that pharmaceutical companies have found a new treatment for Alzheimer’s disease. Over time, none so far have been successful in either stopping or slowing the disease. In fact, the drug manufacturers are required to put that in writing... + más
Here's what disease does to brain, signs to look for: Alzheimer's Q&A | The Advocate
Reimagining Alzheimer’s (Part 6): The Many Effects Of The APOE4 Variant | Forbes
CNBC USA Health November 30, 2022
Alzheimer's is the most common form of dementia, a general term for loss of memory, language, and other thinking abilitiesBrian B. Bettencourt Toronto Star Getty ImagesA trial of an experimental Alzheimer's drug has been hailed as a new era in the beleaguered fight to... + más
Experimental drug appears to slow progression of Alzheimer's disease but raises safety concerns | ABC7
Forbes USA Tech October 22, 2022
A person walks on a suspended rope bridge in the clouds. Extreme attraction.getty This article is the fourth installment in my series on Alzheimer’s disease. Read more about Alzheimer’s disease in , , and of the series. The pharmaceutical and biotech companies, Eisai and... + más
COVID-19 in seniors linked to increased Alzheimer’s risk, study finds | Portland Press Herald
Variety of factors play a role in the development of Alzheimer's | The Advocate
Newsweek USA Health September 24, 2022
The Alzheimer's Association defines Alzheimer's as a brain disease that causes a slow decline in memory, thinking and reasoning skills. Dementia refers to the symptoms of Alzheimer's that can worsen over time.They predict that by 2050, the number of people aged 65... + más
There's a growing dementia crisis in the veteran community: Alzheimer's Q&A | The Advocate
Portland Press Herald USA Health September 24, 2022
A study using the electronic health records of more than 6 million Americans over age 65 found that those who had COVID-19 ran a greater risk of receiving a new diagnosis of Alzheimer’s disease within a year. The study, led by researchers at Case Western Reserve University... + más
How To Spot The Early Signs Of Alzheimer's | Newsweek
About iurex | Privacy Policy | Disclaimer |